A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors

Hodgkin lymphoma (HL) is a hematopoietic malignancy of B-cells that has a bimodal distribution with respect to age and incidence. With the introduction of doxorubicin (Adriamycin), bleomycin, vinblastine, and dacarbazine (ABVD) and radiation combined, the prognosis of HL has significantly improved,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schimmoeller, Christopher J, Bastian, Craig, Fleming, Jessica, Morales, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411984/
https://www.ncbi.nlm.nih.gov/pubmed/37565112
http://dx.doi.org/10.7759/cureus.41660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411984/
https://www.ncbi.nlm.nih.gov/pubmed/37565112
http://dx.doi.org/10.7759/cureus.41660

Ejemplares similares